Investment
Features
FeesSafety
Academy
More
Pluang+

BlockchainK2 plans private placement to raise $130,000 for working capital at $0.07/share

Company Fundamentals
22 Sep 2026
Newsfile Corp
View Source
Neutral
BlockchainK2 plans private placement to raise $130,000 for working capital at $0.07/share

BlockchainK2 Corp. announced a private placement offering up to 1,857,143 common shares at $0.07 each to raise up to $130,000. The funds will be used for general working capital. The company has canceled a previous private placement planned for February 2026. The offering is subject to regulatory approvals, including from the TSX Venture Exchange, and all shares will have a four-month hold period.

BlockchainK2's proposed private placement offering provides context for readers interested in market activity. For readers following US stocks on Pluang, here is the market snapshot as of Sep 22, 2026 18:42 WIB: out of 150 priced stocks, 99 rose and 46 fell. Notable movers include GRAB at USD 3.10 with a 1-day change of +6.53% and a typical hold time of 94 days, BB at USD 9.00 with a 1-day change of +5.51% and a typical hold time of 50 days, and GME at USD 23.85 with a 1-day change of +4.79% and a typical hold time of 61 days.

More News

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...

Company Fundamentals
Bearish
39 minutes ago
Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...

Company Fundamentals
Bearish
45 minutes ago
Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...

Market News
Bullish
1 hour ago
Netflix stock downgraded by HSBC and Wells Fargo over falling viewer engagement.

Netflix stock downgraded by HSBC and Wells Fargo over falling viewer engagement.

HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...

Market News
Bearish
1 hour ago
FormFactor director sells 2,100 shares, signaling insider stock movement

FormFactor director sells 2,100 shares, signaling insider stock movement

A director at FormFactor sold 2,100 shares, indicating a notable insider transaction. Such sales can reflect personal financial decisions or strategic portfolio adjustments by company insiders. Investors often watch these moves for potential signals ...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App